Literature DB >> 8993860

Infections in solid-organ transplant recipients.

R Patel1, C V Paya.   

Abstract

Solid-organ transplantation is a therapeutic option for many human diseases. Infections are a major complication of solid-organ transplantation. All candidates should undergo a thorough infectious-disease screening prior to transplantation. There are three time frames, influenced by surgical factors, the level of immunosuppression, and environmental exposures, during which infections of specific types most frequently occur posttransplantation. Most infections during the first month are related to surgical complications. Opportunistic infections typically occur from the second to the sixth month. During the late posttransplant period (beyond 6 months), transplantation recipients suffer from the same infections seen in the general community. Opportunistic bacterial infections seen in transplant recipients include those caused by Legionella spp., Nocardia spp., Salmonella spp., and Listeria monocytogenes. Cytomegalovirus is the most common cause of viral infections. Herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and others are also significant pathogens. Fungal infections, caused by both yeasts and mycelial fungi, are associated with the highest mortality rates. Mycobacterial, pneumocystis, and parasitic diseases may also occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8993860      PMCID: PMC172945          DOI: 10.1128/CMR.10.1.86

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  776 in total

1.  Paecilomyces cellulitis in a renal transplant patient: successful treatment with intravenous miconazole.

Authors:  L F Harris; B M Dan; L B Lefkowitz; R H Alford
Journal:  South Med J       Date:  1979-07       Impact factor: 0.954

2.  Prophylactic use of interferon in renal allograft recipients.

Authors:  W Weimar; L D Lameijer; V G Edy; H Schellekens
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

3.  Thiabendazole treatment of severe strongyloidiasis in a hemodialyzed patient.

Authors:  J D Schumaker; J D Band; G L Lensmeyer; W A Craig
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

4.  Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.

Authors:  S H Cheeseman; R H Rubin; J A Stewart; N E Tolkoff-Rubin; A B Cosimi; K Cantell; J Gilbert; S Winkle; J T Herrin; P H Black; P S Russell; M S Hirsch
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

5.  Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients.

Authors:  P A Thomas; M F Mozes; O Jonasson
Journal:  Arch Surg       Date:  1979-05

6.  Tuberculous joint disease in transplant patients.

Authors:  N L Ascher; R L Simmons; S Marker; J Klugman; J S Najarian
Journal:  Am J Surg       Date:  1978-06       Impact factor: 2.565

7.  Pumonary aspergillosis during hospital renovation.

Authors:  P M Arnow; R L Andersen; P D Mainous; E J Smith
Journal:  Am Rev Respir Dis       Date:  1978-07

8.  Candida pyarthrosis of the hip and renal homotransplant. Report of a case treated by femoral head and neck resection and 5-fluorocytosine.

Authors:  E E Specht
Journal:  Clin Orthop Relat Res       Date:  1977 Jul-Aug       Impact factor: 4.176

9.  Fungal infections in renal transplant recipients.

Authors:  R J Howard; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1978-11       Impact factor: 12.969

10.  Listeria infection in transplant patients. Five cases and a review of the literature.

Authors:  N L Ascher; R L Simmons; S Marker; J S Najarian
Journal:  Arch Surg       Date:  1978-01
View more
  96 in total

1.  Comparison of two commercial methods for measurement of cytomegalovirus load in blood samples after renal transplantation.

Authors:  C Y Tong; L E Cuevas; H Williams; A Bakran
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.

Authors:  R R Razonable; R A Brown; M J Espy; A Rivero; W Kremers; J Wilson; C Groettum; T F Smith; C V Paya
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 3.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

4.  High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.

Authors:  F Baldanti; P Grossi; M Furione; L Simoncini; A Sarasini; P Comoli; R Maccario; R Fiocchi; G Gerna
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 5.  [Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics].

Authors:  Miriam Wittek; Hans Wilhelm Doerr; Regina Allwinn
Journal:  Med Klin (Munich)       Date:  2010-05-26

6.  In vitro susceptibility of Candida isolates from organ transplant recipients to newer antifungals.

Authors:  Alexandra Geusau; Lukasz Antoniewicz; Christine Poitschek; Elisabeth Presterl; Birgit Willinger
Journal:  Mycopathologia       Date:  2014-03-29       Impact factor: 2.574

7.  Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection.

Authors:  Laura K Mackay; Linda Wakim; Catherine J van Vliet; Claerwen M Jones; Scott N Mueller; Oliver Bannard; Douglas T Fearon; William R Heath; Francis R Carbone
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

8.  Hemorrhagic herpes zoster.

Authors:  Christoph Steininger; Joakim Huber; Alexander Hauswirth
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 9.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

10.  Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.

Authors:  C Y Tong; L Cuevas; H Williams; A Bakran
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.